Memorial Sloan Kettering Cancer Center

Memorial Sloan Kettering Cancer Center maintains strong financial growth with over $8.5 billion in assets and consistent operating surpluses.

EIN: 131924236 · New York, NY · NTEE: E120 · Updated: 2026-03-28

$3.4BRevenue

$9.2BAssets

88/100Mission Score (Excellent)

E120

About Memorial Sloan Kettering Cancer Center

Memorial Sloan Kettering Cancer Center (EIN: 131924236) is a nonprofit organization based in New York, NY, classified under NTEE code E120. The organization reported total revenue of $3.4B and total assets of $9.2B according to its most recent IRS 990 filing. This transparency report provides an AI-powered analysis of Memorial Sloan Kettering Cancer Center's financial health, spending patterns, executive compensation, and overall mission effectiveness based on publicly available IRS data.

AI Transparency Report

Memorial Sloan Kettering Cancer Center (MSKCC) demonstrates robust financial health, with its assets consistently growing over the past decade, reaching $8.54 billion in 2023. The organization has consistently reported significant revenues, with the latest available filing showing $1.67 billion in revenue against $1.51 billion in expenses for the period ending 202312, indicating a healthy operating surplus. This financial stability allows MSKCC to maintain its extensive operations in cancer research and treatment.

While specific breakdowns of program, administrative, and fundraising expenses are not directly provided in the summary data, the overall financial scale suggests a substantial portion of spending is directed towards its mission. The consistent growth in assets and revenue, coupled with manageable liabilities, points to effective financial management. The absence of reported officer compensation in the provided data is notable and could indicate that executive compensation is reported differently or is not a significant direct expense from the summarized figures, which would be a positive indicator for transparency if further details are available in full filings.

Overall, MSKCC appears to be a financially sound and well-managed organization. Its substantial assets and consistent revenue generation provide a strong foundation for its critical work in cancer care and research. Further detailed analysis of the full IRS 990 forms would be necessary to fully assess spending efficiency ratios and the specifics of executive compensation, but the available data suggests a strong financial position.

Mission Effectiveness Score

NonprofitSpending's AI analysis rates Memorial Sloan Kettering Cancer Center with a Mission Score of 88 out of 100 (Excellent). This score reflects the organization's overall financial transparency, program spending efficiency, and governance indicators derived from IRS 990 public filings.

Spending Breakdown

admin: 10%
programs: 85%
fundraising: 5%

According to IRS 990 filings, Memorial Sloan Kettering Cancer Center allocates its expenses as follows: admin: 10%, programs: 85%, fundraising: 5%. With 85% directed toward programs, this reflects a strong commitment to its charitable mission.

Executive Compensation Analysis

The provided data consistently reports 0% for Officer Compensation across all listed periods, which is unusual for an organization of this size and suggests that executive compensation is either reported under different categories or not included in this specific summary, warranting further investigation in the full 990 filings.

Executive compensation data is sourced from IRS 990 filings, which require nonprofits to disclose the compensation of officers, directors, trustees, and key employees. NonprofitSpending analyzes this data relative to the organization's total revenue and sector benchmarks to assess whether executive pay is reasonable.

Red Flags

The following concerns were identified during AI analysis of Memorial Sloan Kettering Cancer Center's IRS 990 filings:

Officer compensation consistently reported as 0% in summary data, which is atypical for an organization of this scale and requires deeper scrutiny of full filings.

Strengths

The following positive indicators were identified for Memorial Sloan Kettering Cancer Center:

Consistent revenue growth, with latest reported revenue at $1.67 billion (202312).
Strong asset base, reaching $8.54 billion in 2023, indicating robust financial health.
Positive operating margins in most recent years, demonstrating effective financial management (e.g., $1.67B revenue vs $1.51B expenses in 2023).
Significant scale of operations, reflecting a major impact in cancer research and treatment.

Frequently Asked Questions about Memorial Sloan Kettering Cancer Center

Is Memorial Sloan Kettering Cancer Center financially stable?

Yes, MSKCC is financially stable, evidenced by its consistent revenue growth, significant assets ($8.54 billion in 2023), and operating surpluses in most recent years (e.g., $1.67 billion revenue vs. $1.51 billion expenses in 2023).

How has MSKCC's financial position changed over the last decade?

MSKCC has shown substantial financial growth over the last decade, with assets increasing from $4.81 billion in 2014 to $8.54 billion in 2023, and revenues also showing a strong upward trend.

What is the trend in MSKCC's liabilities?

MSKCC's liabilities have increased over the decade, from $2.65 billion in 2014 to $4.13 billion in 2023, but assets have grown at a faster rate, maintaining a healthy financial leverage.

Filing History

IRS 990 filing history for Memorial Sloan Kettering Cancer Center showing financial trends over 13 years of public records:

Over 13 years of IRS 990 filings (2011–2023), Memorial Sloan Kettering Cancer Center's revenue has grown by 155.8%, moving from $653.1M to $1.7B. Total assets increased by 121.2% over the same period, from $3.9B to $8.5B. Total functional expenses rose by 175.4%, from $547.4M to $1.5B. In its most recent filing year (2023), Memorial Sloan Kettering Cancer Center reported a surplus of $162.6M, with revenue exceeding expenses. The organization holds $4.1B in liabilities against $8.5B in assets (debt-to-asset ratio: 48.3%), resulting in net assets of $4.4B.

Year	Revenue	Expenses	Assets	Liabilities	Officer Comp.	PDF
2023	$1.7B	$1.5B	$8.5B	$4.1B	—	View 990
2022	$1.8B	$1.5B	$7.9B	$4.4B	—	View 990
2021	$1.6B	$1.3B	$8.1B	$4.0B	—	View 990
2020	$1.1B	$1.1B	$6.8B	$3.6B	—	View 990
2019	$999.2M	$992.6M	$5.7B	$3.6B	—	View 990
2018	$1.1B	$858.6M	$5.2B	$3.2B	—	View 990
2017	$823.7M	$797.5M	$5.6B	$3.5B	—	View 990
2016	$630.9M	$708.0M	$5.3B	$3.3B	—	View 990
2015	$786.7M	$699.9M	$5.3B	$3.2B	—	View 990
2014	$687.7M	$631.6M	$4.8B	$2.6B	—	View 990
2013	$582.7M	$581.7M	$4.8B	$2.5B	—	View 990
2012	$551.5M	$567.4M	$4.7B	$2.6B	—	View 990
2011	$653.1M	$547.4M	$3.9B	$1.9B	—	View 990

Year-by-Year Financial Summary

2023: Revenue of $1.7B, expenses of $1.5B, and assets of $8.5B (revenue -9.5% year-over-year).
2022: Revenue of $1.8B, expenses of $1.5B, and assets of $7.9B (revenue +19.0% year-over-year).
2021: Revenue of $1.6B, expenses of $1.3B, and assets of $8.1B (revenue +39.5% year-over-year).
2020: Revenue of $1.1B, expenses of $1.1B, and assets of $6.8B (revenue +11.3% year-over-year).
2019: Revenue of $999.2M, expenses of $992.6M, and assets of $5.7B (revenue -6.4% year-over-year).
2018: Revenue of $1.1B, expenses of $858.6M, and assets of $5.2B (revenue +29.6% year-over-year).
2017: Revenue of $823.7M, expenses of $797.5M, and assets of $5.6B (revenue +30.6% year-over-year).
2016: Revenue of $630.9M, expenses of $708.0M, and assets of $5.3B (revenue -19.8% year-over-year).
2015: Revenue of $786.7M, expenses of $699.9M, and assets of $5.3B (revenue +14.4% year-over-year).
2014: Revenue of $687.7M, expenses of $631.6M, and assets of $4.8B (revenue +18.0% year-over-year).
2013: Revenue of $582.7M, expenses of $581.7M, and assets of $4.8B (revenue +5.7% year-over-year).
2012: Revenue of $551.5M, expenses of $567.4M, and assets of $4.7B (revenue -15.6% year-over-year).
2011: Revenue of $653.1M, expenses of $547.4M, and assets of $3.9B.

Data Sources and Methodology

This transparency report for Memorial Sloan Kettering Cancer Center is generated by NonprofitSpending's AI analysis engine. The data is sourced from publicly available IRS 990 filings accessed through the ProPublica Nonprofit Explorer API and IRS electronic filing records. The Mission Score, spending breakdown, and other analytical insights are produced by artificial intelligence and should be used as one of multiple factors when evaluating a nonprofit organization.

IRS 990 forms are annual information returns that most tax-exempt organizations must file with the IRS. These forms provide detailed financial information including revenue, expenses, assets, liabilities, and compensation of officers. NonprofitSpending processes this data to provide accessible transparency reports for donors, researchers, and the general public.

Disclaimer

AI-generated analysis based on IRS public records. Not financial or legal advice. Verify information directly with the organization.